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ABSTRACT
Silver nanoparticles synthesized from aqueous extract of mushroom Pleurotus ostreatus exhibited inhibitory effect at the concentration 
of 12.5, 25, 50, and 100 mg/ml against some pathogenic bacteria and fungi such as Candida albicans, Candida guilliermondii, Candida 
krusei, Candida zeylanoides, Geotrichum klebahnii, Staphylococcus aureus, Pseudomonas aeruginosa, and Escherichia coli. The maximum 
inhibition zone was observed against C. zeylanoides at the concentration of 100 mg/ml was 24.5 mm, while the minimum inhibition zone 
was observed against Geotrichum at the concentration of 25 mg/ml was 8 mm and the concentration of 12.5 mg/ml was not effective 
against some species.
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INTRODUCTION
A new dimension of the metal microbial interaction has been explored for the synthesis of metal nanoparticles such as gold, silver, cadmium, zirconia, and silica 
titanium.[1] Silver compounds have been used to treat burns, 
wounds, and infections as well as in preventing bacterial 
colonization of prostheses and catheters.[2] Various salts of silver 
and their derivatives are used as antimicrobial agents. Nanosized 
silver particles exhibit antimicrobial properties. Nanoparticles 
of silver have been studied as a medium for antibiotic delivery, 
and to synthesize composites for use as disinfecting filters and 
coating materials.[3] The nanoparticles were important due 
to their emission properties. These nanoparticles are used for 
wide range of application.[4,5] Antibacterial activity is related to 
compounds that locally kill bacteria or slow down their growth, 
without being in general toxic to surrounding tissue.[6] The high 
bactericidal activity is certainly due to the silver cations released 
from Ag nanoparticles (AgNPs) that act as reservoirs for the Ag+ 
bactericidal agent.[7] Severe fungal infections have significantly 
contributed to the increasing morbidity and mortality,[8] 
immunocompromised patients who need intensive treatment 
including broad-spectrum antibiotic therapy,[9,10] and Candida 
spp. represent one of the most common pathogens which are 
responsible for fungal infections often causing hospital-acquired 
sepsis with an associated mortality rate of up to 40%.[11] 
Currently, the majority of yeast species are resistant the available 
antifungal therapy[12,13] such as on polyenes (amphotericin B), 
triazoles (fluconazole, itraconazole, voriconazole, and 
posaconazole) or echinocandins (caspofungin, micafungin, and 
anidulafungin) which exhibit their toxicity, adverse effects, and 
drug interaction.[14,15]
The objective of this work is to evaluate the effect of a 
biosynthesized AgNPs product against some Candida spp. and 
bacteria species to determine how AgNPs interact with the 
growth of microbial cells.
MATERIALS AND METHODS
The mushroom Pleurotus ostreatus was obtained from fruit 
body grown on peach tree in Salah-Alddin Province.
Preparation of Hot Aqueous Extracts of 
Mushroom
The oven dried mushroom was blended; the obtained 
powder was soaked in distilled water at a ratio of 1:10 
(w/v) and boiled with agitation at 60 ± 2°C for 30 min. 
The boiled mushroom powder was then left covered for 
30 min. Residues were then removed by filtration through 
gauze and further centrifugation (10,000 rpm, 30 min, and 
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4°C). Supernatants were then collected and filtered through 
Whatman No. 1 filter paper. After that, freeze dried extract 
powders were obtained using freeze dryer and stored 
at 4 ± 2°C.[16]
Biosynthesized AgNPs from P. ostreatus
Silver nitrate (1 × 10−3) AgNO3 stock solution was 
prepared in sterile deionised triple - distilled water and the 
subsequent dilutions were made from this stock solution. 
The bulk amount of (10) mg/ml of aqueous extract solution 
of is prepared with sterile distilled water and filtered 
through syringe filter (0.2) µm. Based on the result of a 
preliminary trial, 2–7 ml of 10 mg/ml of an aqueous extract 
of P. ostreatus (P2) were filled with sterile distilled water to 
a total of 10 ml.
After that, the solution is added to 5 ml of (1 × 10−3) 
M aqueous AgNO3 solution and kept at room temperature 
and exposed under ultraviolet (UV) (365) nm (long UV). 
After 24 h incubation, the light yellow color of the mixture 
solution turned to dark yellow indicating the formation of 
AgNPs.[17]
Candida Isolates
All Candida isolates Candida albicans, Candida guilliermondii, 
Candida krusei, Candida zeylanoides, and Geotrichum 
klebahnii were procured from AL-Yarmouk Teaching Hospital. 
Mycological identification was carried out for all samples by 
commercial carbohydrate assimilation systems such as the API 
20 C test kit.[18] All yeast isolates were inoculated in a primary 
isolation medium such as Sabouraud Dextrose Agar (SDA) 
medium for 2–3 days at 37°C.
Antimicrobial Activity of AgNPs (Well 
Diffusion Method)
The synthesized AgNP was tested for antimicrobial activity by 
agar well diffusion method against pathogenic microbes for all 
the previously mentioned bacteria and yeast species. The pure 
cultures of bacteria and yeast were subcultured on nutrient and 
SDA subsequently. Each strain was swapped homogeneously 
onto the individual plates using sterile cotton swabs. Wells of 
10 mm diameter were done. The concentration of AgNPs was 
poured on each well. After 24 h of incubation the diameter of 
inhibition zone was measured. Three replicates of experiments 
were carried out.[19]
RESULTS
The formation of AgNPs was confirmed by the UV-visible 
spectrophotometry, which showed a strong peak within the 
range of 200–500 nm, “Figure 1.”
Intensity of Particle Size Distribution 
Analysis
To know the size of synthesized AgNPs, size distribution 
analysis was performed using light scattering in aqueous 
solution. The results showed that the size of the particles 
ranged from 16 to 104 nm. The average size of AgNPs was 
determined to be 49 ± 16 nm as in “Figures 2 and 3.”
DISCUSSION
Antimicrobial mechanisms of nanomaterials are not fully 
understood, but it is proposed that when they come into 
contact with cells, they provoke the production of reactive 
oxygen specie, cell membrane disruption, mitochondrial 
damage, and DNA damage.[20]
Antifungal activity by AgNPs has been proved against 
different Candida species, including C. albicans, since 
microbial cells were inhibited using AgNPs.[21] Furthermore, 
it was reported that AgNPs damage the structure of the cell 
membrane in C. albicans producing “holes” on the surface of 
the cells and thus inhibiting the budding process.[22]
Figure 1: Ultraviolet-visible absorption spectra of silver nanoparticles 
after bioreduction by Pleurotus ostreatus mushroom aqueous extract
Figure 2: Size of silver nanoparticles
Figure 3: Intensity of particle size distribution of Pleurotus ostreatus 
dried mushroom aqueous extract
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The antifungal properties of AgNPs against C. albicans have 
been demonstrated in some other studies, although reported 
minimum inhibitory concentration values are different from 
the ones we found in this work.[21-24] Such differences could be 
due to the nature of the particles used, the difference in size 
being particularly important. It is known that size and shape 
of metallic nanoparticles influence their chemical, optical, and 
thermal properties.[25]
The effectiveness of AgNPs against bacteria is clearly 
demonstrated, and in fact, AgNPs were shown to be effective 
against E. coli, with cells showing formation of “pits” in the cell wall. 
The AgNPs were found to accumulate in the bacterial membrane 
and some of them were reported to successfully penetrate into the 
cells.[26] Similar results were found in E. coli and Vibrio cholera; 
it was established that AgNPs provoked changes mainly in the 
cell membrane morphology, producing a significant increase in 
their permeability, thus affecting the proper transport through the 
plasma membrane, and resulting eventually in cell death. They 
also reported that silver NPs with small diameters penetrated 
into the cells.[27] In our study, Ag NPs were found surrounding C. 
albicans cells, similar to the results found in bacteria.[27-29]
In this study, the aqueous extracts of mushroom (P. ostreatus) 
gave showed (ve−) results against all microbial species when 
used as a control [Figures 4 and 5], while the biosynthesized 
AgNPs gave showed (ve+) result as an inhibition zones for 
different microbial species [Figures 4 and 5, Tables 1,2].
Table 1: The inhibitory effect of AgNPs (mm) against Candida and bacterial species
Candida spp. Inhibition zone (mm)
12.5 mg/ml 25 mg/ml 50 mg/ml 100 mg/ml
Candida albicans --- 10 12 16
Candida guillermondii --- 10 15.5 20
Candida krusie --- 14.5 15.5 19
Geotrichum ktebahnii --- 8 14 20
Candida zeylanoides 15 18.5 21 24.5
Staphylococcus aureus 10 11 12 16
Pseudomonas aeroginosa --- 12 13 14
Escherichia coli 10 12 13 15
AgNPs: Silver nanoparticles
Table 2: Statistical analysis of the inhibitory effect of AgNPs (mm) on Candida and bacterial isolates
Microbial species Control AgNPs (mg/ml) s
12.5 25 50 100
Candida albicans <0.001d 0±0.0d 10±0.57c 12±0.58b 16±0.58a
Candida guillermondii <0.001d 0±0.0d 15±0.58c 15.6±0.33b 20±0.57a
Candida krusie <0.001d 0±0.0d 14.5±0.28c 15.6±0.16b 19±0.57a
Geotrichumktebahnii <0.001d 0±0.0d 8±0.57c 14±0.58b 20±0.58a
Candida zeylanoides <0.001e 15±0.57d 18.5±0.28c 21±0.57b 24.5±0.28a
Staphylococcus aureus <0.001d 10±0.58c 11±0.57bc 12±0.57b 16±0.58a
Pseudomonas aeroginosa <0.001c 0±0.0c 12±0.58b 13±0.58ba 14±0.57a
Escherichia coli <0.001d 10±0.57c 12±0.58b 13±0.57b 15±0.58a
The findings were described in the table represent the average of three replicates±standard error. Small letters (a, b, c, d, e, ba, and ac) indicate to comparison 
between means in column, similar letters are non-significantly differences between means at (P≤0.05), using (LSD test). AgNPs: Silver nanoparticles
Figure 4: Inhibition zone of silver nanoparticles against several isolates of bacteria; (a) Staphylococcus aureus, (b) Pseudomonas aeroginosa 
(c), Escherichia coli
cba
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However, despite the clear antimicrobial properties of 
AgNPs, their potential use in the clinic should be carefully 
evaluated since there is a lack of basic knowledge on the 
potentially different antimicrobial properties of AgNPs which 
may vary depending on many factors, including the method of 
synthesis, size, shape, functionalizing agent, and application 
method and also their interaction in more complex systems 
such as plants, animals, and humans.
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